
TuHURA Biosciences, Inc.: updates and filings
Price
$1.25
November 20, 2026Market cap $80M
What Ploutos Investor adds for TuHURA Biosciences
Part of Ploutos Investor, €9.99 a month
- The full history: 5 fiscal years, from FY2011
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
November 2026
September 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 18, 2026New material financial obligationForm8-K
- Nov 13, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 13, 2026Results of operationsForm8-K
- Nov 6, 2026New material financial obligationForm8-K
- Oct 16, 2026New material financial obligationForm8-K
- Sep 24, 2026New material financial obligationForm8-K
- Sep 17, 2026New material financial obligationForm8-K
- Sep 17, 2026Officer or director change (amendment)Form8-K/A
- Sep 16, 2026Officer or director changeForm8-K
- Sep 4, 2026New material financial obligationForm8-K
- Aug 28, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Aug 21, 2026New material financial obligationForm8-K
- Aug 19, 2026Unregistered sale of shares, shareholder voteForm8-K
- Aug 14, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 14, 2026Results of operationsForm8-K
- Aug 13, 2026New material financial obligationForm8-K
- Jul 29, 2026New material financial obligationForm8-K
- Jul 9, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Jul 9, 2026Additional annual meeting materialFormDEFA14A
- Jul 9, 2026Annual meeting proxy statementFormDEF 14A
- Jul 7, 2026New material financial obligationForm8-K
- Jun 26, 2026Preliminary proxy statementFormPRE 14A
- Jun 17, 2026Material eventForm8-K
- May 29, 2026New material financial obligationForm8-K
- May 15, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 18, 2026 | 8-K | New material financial obligation | Document |
| Nov 13, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 13, 2026 | 8-K | Results of operations | Document |
| Nov 6, 2026 | 8-K | New material financial obligation | Document |
| Oct 16, 2026 | 8-K | New material financial obligation | Document |
| Sep 24, 2026 | 8-K | New material financial obligation | Document |
| Sep 17, 2026 | 8-K | New material financial obligation | Document |
| Sep 17, 2026 | 8-K/A | Officer or director change (amendment) | Document |
| Sep 16, 2026 | 8-K | Officer or director change | Document |
| Sep 4, 2026 | 8-K | New material financial obligation | Document |
| Aug 28, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Aug 21, 2026 | 8-K | New material financial obligation | Document |
| Aug 19, 2026 | 8-K | Unregistered sale of shares, shareholder vote | Document |
| Aug 14, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 14, 2026 | 8-K | Results of operations | Document |
| Aug 13, 2026 | 8-K | New material financial obligation | Document |
| Jul 29, 2026 | 8-K | New material financial obligation | Document |
| Jul 9, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Jul 9, 2026 | DEFA14A | Additional annual meeting material | Document |
| Jul 9, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Jul 7, 2026 | 8-K | New material financial obligation | Document |
| Jun 26, 2026 | PRE 14A | Preliminary proxy statement | Document |
| Jun 17, 2026 | 8-K | Material event | Document |
| May 29, 2026 | 8-K | New material financial obligation | Document |
| May 15, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Aug 17, 2010. Of its note and share prospectuses (424B, FWP), the newest 40 of 42.
The full analysis
What do TuHURA Biosciences's filings show?
The filings are where every one of TuHURA Biosciences's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.